by GoozNews ~ 11 Nov 2009 05:44pm Kay Dickerson, an epidemiologist at Johns Hopkins University, has a new study in the Annals of Family Medicine comparing the outcomes of a dozen studies of Neurontin (gabepentin) to their original protocols. …
Read Original Story: Neurontin Studies Cooked the Books – GoozNew (blog)
Nov. 11 (Bloomberg) — Researchers say trials of Pfizer Inc.’s Neurontinepilepsy treatment for uses that were not yet approved may have been skewed to emphasize favorable results. Comparisons of internalcompanydocuments with published …
Read Original Story: Data From Studies of Pfizer Neurontin Drug May Have Been Skewed – Bloomberg
Crime does pay in the billion-dollar world of pharmaceuticals. Drug companies this decade have paid $7 billion in fines as a result of criminal and civil cases brought against them for illegally marketing their products, but the penalties pale in …
Read Original Story: Drug Companies Find it Cost-Effective to Pay Fines and Keep Breaking Laws – AllGov
WEDNESDAY, Nov. 11 (HealthDay News) — An unusual look at internaldocuments from a pharmaceutical company suggests that clinical data was manipulated to make a popular anti-seizure drug, gabapentin (Neurontin), look more effective than it actually was …
Read Original Story: Trial Data on Anti-Seizure Drug Might Have Been Manipulated: Report – Atlanta Journal Constitution
Analysis of a dozen published studies testing possible new uses for a Pfizer Inc. epilepsy drug found that reporting of the results was often misleading, indicating the medicine worked better than internalcompanydocuments showed. …
Read Original Story: Review: Reports on Pfizer drug studies misleading – The Associated Press
Pfizer Inc., the world’s largest drug company, either falsified or omitted negative study results in order to earn broader approvals for its epilepsy drug Neurontin, a new study says. In some cases, Pfizer didn’t followed through on publishing …
Read Original Story: Pfizer Accused of Manipulating Neurontin Study Results – Attorney at Law
CHICAGO (Reuters) – A study of internalcompanydocuments suggests Pfizer Inc altered or omitted unfavorable study findings to expand its epilepsy drug Neurontin’s market, US researchers said on Wednesday, offering a look at how …
Read Original Story: Report Shows Pfizer's Hand in Neurontin Studies – ABC News
